Logo
x

Search

Subscribe Now

IDEAYA Biosciences

IDEAYA Biosciences Nominates IDE034 as a Development Candidate Under Partnership with Biocytogen

IDEAYA Biosciences Nominates IDE034 as a Development Candidate Under Partnership with Biocytogen

  • November 11, 2024
IDEAYA Biosciences Collaborates with Biocytogen to Develop Bispecific ADC Program for Cancer Treatment

IDEAYA Biosciences Collaborates with Biocytogen to Develop Bispecific ADC Program for Cancer Treatment

  • July 31, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.